For the year ending 2025-12-31, CGON has $791,592K in assets. $38,990K in debts. $32,490K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 32,490 | |||
| Marketable securities | 709,665 | |||
| Inventory | 1,565 | |||
| Accounts receivable, net | 688 | |||
| Prepaid expenses and other current assets | 15,067 | |||
| Total current assets | 759,475 | |||
| Total property and equipment, cost | 17,070 | |||
| Less accumulated depreciation | 1,474 | |||
| Property and equipment, net | 15,596 | |||
| Operating lease right-of-use assets | 3,971 | |||
| Intangible assets, net | 575 | |||
| Goodwill | 10,297 | |||
| Other assets | 1,678 | |||
| Total assets | 791,592 | |||
| Accounts payable | 5,714 | |||
| Operating lease liabilities, current portion | 915 | |||
| Accrued expenses and other current liabilities | 24,207 | |||
| Total current liabilities | 30,836 | |||
| Long-term debt | 3,000 | |||
| Operating lease liabilities, net of current portion | 3,106 | |||
| Deferred tax liability | 307 | |||
| Other liabilities | 1,741 | |||
| Total liabilities | 38,990 | |||
| Common stock, 0.0001 par value per share 700,000,000 and 700,000,000 shares authorized as of december 31, 2025 and december 31, 2024, respectively 80,689,128 and 76,154,783 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 8 | |||
| Additional paid-in capital | 1,131,570 | |||
| Accumulated deficit | -378,976 | |||
| Total stockholders' equity | 752,602 | |||
| Total liabilities and stockholders' equity | 791,592 | |||
CG Oncology, Inc. (CGON)
CG Oncology, Inc. (CGON)